Characterization of Three Somatic Mutations in the 3′UTR of RRAS2 and Their Inverse Correlation with Lymphocytosis in Chronic Lymphocytic Leukemia
Cells · 2023
DOI: 10.3390/cells12232687 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Marta Lacuna und 8 weiteren Autor:innen. Beteiligte Einrichtung: Immune System Development and Function Program, Centro Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC)-Univer…. Hauptthemen laut MEDLINE: Leukemia, Lymphocytic, Chronic, B-Cell, Lymphocytosis, Monomeric GTP-Binding Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMHD NIH HHS, Spanish Association against Cancer, Minsterio de Ciencia y Tecnología.
Abstract (Originalsprache)
Chronic lymphocytic leukemia (CLL) is a hematologic malignancy characterized by progressive accumulation of a rare population of CD5+ B-lymphocytes in peripheral blood, bone marrow, and lymphoid tissues. CLL exhibits remarkable clinical heterogeneity, with some patients presenting with indolent disease and others progressing rapidly to aggressive CLL. The significant heterogeneity of CLL underscores the importance of identifying novel prognostic markers. Recently, the RAS-related gene RRAS2 has emerged as both a driver oncogene and a potential marker for CLL progression, with higher RRAS2 expression associated with poorer disease prognosis. Although missense somatic mutations in the coding sequence of RRAS2 have not been described in CLL, this study reports the frequent detection of three somatic mutations in the 3′ untranslated region (3′UTR) affecting positions +26, +53, and +180 downstream of the stop codon in the mRNA. An inverse relationship was observed between these three somatic mutations and RRAS2 mRNA expression, which correlated with lower blood lymphocytosis. These findings highlight the importance of RRAS2 overexpression in CLL development and prognosis and point to somatic mutations in its 3′UTR as novel mechanistic clues. Our results may contribute to the development of targeted therapeutic strategies and improved risk stratification for CLL patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Immune System Development and Function Program, Centro Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas (CSIC)-Universidad Autónoma de Madrid, 28049 Madrid, Spain.
- Departamento de Hematología, Hospital Universitario de Salamanca (HUS-IBSAL), 37007 Salamanca, Spain.
- Centro de Investigación del Cáncer, Instituto de Biología Molecular y Celular del Cáncer and Centro de Investigación Biomédica en Red de Cáncer, CSIC, Universidad de Salamanca, 37007 Salamanca, Spain.
ORCID-Profile: Claudia Cifuentes, Miguel Alcoceba, Miguel Bastos, Xosé R Bustelo
Förderung
- NIMHD NIH HHS
- Spanish Association against Cancer
- Minsterio de Ciencia y Tecnología
- AEI/10.13039/501100011033
- Comunidad de Madrid
- Fundación Ramón Areces
- Instituto de Salud Carlos III
- Health Council of the Junta de Castilla y León
Zitieren
APA
Lacuna, M., Hortal, A. M., Cifuentes, C., Gonzalo, T., Alcoceba, M., Bastos, M., Bustelo, X. R., González, M., & Alarcón, B. (2023). Characterization of Three Somatic Mutations in the 3′UTR of RRAS2 and Their Inverse Correlation with Lymphocytosis in Chronic Lymphocytic Leukemia. Cells. https://doi.org/10.3390/cells12232687
Vancouver
Lacuna M, Hortal AM, Cifuentes C, Gonzalo T, Alcoceba M, Bastos M, et al. Characterization of Three Somatic Mutations in the 3′UTR of RRAS2 and Their Inverse Correlation with Lymphocytosis in Chronic Lymphocytic Leukemia. Cells. 2023. doi:10.3390/cells12232687
BibTeX
@article{Lacuna2023,
author = {Lacuna, Marta and Hortal, Alejandro M and Cifuentes, Claudia and Gonzalo, Tania and Alcoceba, Miguel and Bastos, Miguel and Bustelo, Xosé R and González, Marcos and Alarcón, Balbino},
title = {Characterization of Three Somatic Mutations in the 3′UTR of RRAS2 and Their Inverse Correlation with Lymphocytosis in Chronic Lymphocytic Leukemia},
journal = {Cells},
year = {2023},
doi = {10.3390/cells12232687}
}
EUVIMED